Skip to main content
2025 CRT Conference Main banner
Back

David Erlinge, MD, PhD

Professor, Consultant Interventional Cardiology
Lund University
Lund, Sweden

Dr David Erlinge is Professor of Cardiology at Lund University, Sweden Prof Erlinge is an interventional cardiologist focusing on PCI with a clinical interest in acute coronary syndromes. He is chairman of the Swedish PCI register (SCAAR) member of the board of SWEDEHEART.
He has been involved in the developing and leading registry based randomized clinical trials (RRCT) from TASTE, IFR-SWEDEHEART, DETO2X and was the leader of the pharmaceutical RRCT VALIDATE-SWEDEHEART, DAPA-MI and the diagnostic vulnerable plaque trial PROSPECT II.

Disclosure(s): No financial relationships to disclose

Presentation(s):

Email David